Clinical Trial Update: IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy [Phase 4]

View source ↗

Summary

Phase 4 trial update on intravenous colistin for pulmonary exacerbations in cystic fibrosis patients, focusing on safety and efficacy with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: National Jewish Health | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2022-10-06